Search results
Why many lung cancer patients who have never smoked have worse outcomes
Science Daily· 17 hours agoThe study, published in Nature Communications, shows that lung cancer cells with two particular genetic mutations are more likely to double their genome, which helps them ...
Combined immunotherapy drugs ‘could treat most common form of bowel cancer’
PA Media: Science via Yahoo News· 3 hours agoA combination of two immunotherapy drugs could be used to treat the most common form of bowel cancer...
Tuschen siblings, honorary co-chairs of Heart and Sole Walk, overcome three cancer diagnoses in one...
The Daily Republic, Mitchell, S.D. via Yahoo News· 27 minutes agoJun. 13—MITCHELL — Growing up in the same household, Karla Prangley, Amy Tlam and Scott Tuschen shared meals, a living space and even the occasional sibling disagreement. It's all part of growing ...
Radioactive drugs strike cancer with precision
Knowable Magazine via Yahoo News· 1 day agoThe Endocyte acquisition brought a PSMA-targeted agent that would prove to be a real game-changer — both for patients with certain difficult-to-treat...
UroGen Catapults On 'Unprecedented' Results For Gel-Based Cancer Drug
Investor's Business Daily· 4 hours agoUroGen stock rocketed Thursday on "unprecedented" test results for its bladder cancer treatment, a...
Blue Cross Blue Shield of Michigan dropping coverage of weight loss drugs
CBS News· 3 hours agoMichigan's largest insurance company said it will begin eliminating coverage of various weight loss...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoAnd, last month, Pfizer unveiled positive results from a lung cancer study. The company tested its ...
Why many people with lung cancer who have never smoked don't respond well to treatments
MedicalNewsToday via AOL· 16 hours agoResearchers have honed in on two genetic mutations they say may be responsible for the...
Innovent Receives Fast Track Designation from the U.S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as...
Yucaipa News Mirror· 1 day agoFood and Drug Administration (FDA) has granted Fast Track Designation to its TOPO1i anti-CLDN18.2 ADC (R&D code: IBI343), for the treatment of advanced unresectable or metastatic ...
Their cancers can't be cured. But new treatments are changing the length, and quality, of their...
Gannett via AOL· 14 hours ago"We want to take away the guesswork to the extent possible that technology allows us, and them give...
